We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Microscope Technology Breaks Smallness Barrier

By Biotechdaily staff writers
Posted on 30 Sep 2004
Using a sophisticated microscope with new computerized imaging technology, scientists have broken through the obstacle of how small something can be seen--to a record, atom-scale 0.6 angstrom. More...
Researchers obtained the improved resolution with a 200-kilovolt Z-contrast scanning transmission electron microscope (STEM), aided by a new technology called aberration correction. The direct images have been seen as verification of atom-scale resolution below one angstrom, and provide researchers with an important tool for creating advanced materials.

Scientists from the Oak Ridge [U.S.] National Laboratory (ORNL; Oak Ridge, TN, USA) described their results in the September 17, 2004, issue of the journal Science. "Looking down on a silicon crystal, we can see atoms that are only 0.78 angstroms apart, which is the first unequivocal proof that we're getting sub-angstrom resolution. The same image shows that we're getting resolution in the 0.6 angstrom range,” stated Dr. Stephen Pennycook, a researcher in the ORNL condensed matter sciences division. An angstrom is an atomic scale unit of measure of one-billionth of a meter, about the diameter of an atom.

The researchers worked with Nion Co. (Kirkland, WA, USA) to produce images of pairs of silicon atom columns in a crystal. Nion provided the aberration-correction technology that corrects errors introduced to the images by defects in the electron lenses. Even though the concept is not new, this technology was only recently made workable by improvements in computation methods and image-analysis algorithms.

Aberration-corrected microscopy provides a direct image with fewer chances for artifacts. Uncorrected microscopy can achieve sub-angstrom resolution by combining a group of many images to achieve one image, but it also increases the introduction of artifacts into the images.

By demonstrating columns of atoms and the position of introduced "dopant” atoms, the atom-scale images provide a new understanding of materials' characteristics, according to Dr. Pennycook. The enhanced images also enable scientists to more accurately model and predict the behavior of materials on computers before time-consuming and costly bench tests are performed.

"With aberration correction you can see everything better, basically. It's always better to see what's what. For the material, chemical, and nanosciences, you want to see what is going on at the atomic scale--how atoms bond and how things work,” said Dr. Pennycook.


Related Links:
Oak Ridge National Laboratory

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.